1. Home
  2. ALDX vs FET Comparison

ALDX vs FET Comparison

Compare ALDX & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • FET
  • Stock Information
  • Founded
  • ALDX 2004
  • FET 2005
  • Country
  • ALDX United States
  • FET United States
  • Employees
  • ALDX N/A
  • FET N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • FET Metal Fabrications
  • Sector
  • ALDX Health Care
  • FET Industrials
  • Exchange
  • ALDX Nasdaq
  • FET Nasdaq
  • Market Cap
  • ALDX 342.3M
  • FET 309.5M
  • IPO Year
  • ALDX 2014
  • FET 2012
  • Fundamental
  • Price
  • ALDX $5.09
  • FET $26.51
  • Analyst Decision
  • ALDX Strong Buy
  • FET
  • Analyst Count
  • ALDX 2
  • FET 0
  • Target Price
  • ALDX $9.50
  • FET N/A
  • AVG Volume (30 Days)
  • ALDX 776.7K
  • FET 100.3K
  • Earning Date
  • ALDX 11-06-2025
  • FET 10-30-2025
  • Dividend Yield
  • ALDX N/A
  • FET N/A
  • EPS Growth
  • ALDX N/A
  • FET N/A
  • EPS
  • ALDX N/A
  • FET N/A
  • Revenue
  • ALDX N/A
  • FET $801,867,000.00
  • Revenue This Year
  • ALDX N/A
  • FET N/A
  • Revenue Next Year
  • ALDX $63.48
  • FET $0.45
  • P/E Ratio
  • ALDX N/A
  • FET N/A
  • Revenue Growth
  • ALDX N/A
  • FET 3.86
  • 52 Week Low
  • ALDX $1.14
  • FET $12.78
  • 52 Week High
  • ALDX $7.20
  • FET $27.72
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 37.78
  • FET 62.88
  • Support Level
  • ALDX $5.48
  • FET $25.46
  • Resistance Level
  • ALDX $5.88
  • FET $27.72
  • Average True Range (ATR)
  • ALDX 0.29
  • FET 0.91
  • MACD
  • ALDX -0.10
  • FET -0.07
  • Stochastic Oscillator
  • ALDX 10.63
  • FET 61.59

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

Share on Social Networks: